Questions and Answers
What is the generic name for Anoro Ellipta?
Umeclidinium bromide and vilanterol trifenatate
What drug class does Anoro Ellipta belong to?
Combination drug to treat COPD
What is the primary use of Anoro Ellipta?
COPD
Which of the following are warnings associated with Anoro Ellipta? (Select all that apply)
Signup and view all the answers
Which of the following are adverse effects of Anoro Ellipta? (Select all that apply)
Signup and view all the answers
Study Notes
Anoro Ellipta Overview
- Generic Name: Umeclidinium bromide and vilanterol trifenatate.
- Formulation: Powdered inhaler designed for respiratory treatment.
Drug Class
- Classified as a combination drug.
- Specifically indicated for Chronic Obstructive Pulmonary Disease (COPD).
- NOT suitable for asthma treatment.
Intended Use
- Approved solely for COPD management.
- Not effective for acute bronchospasm or asthma exacerbations.
Warnings and Precautions
- Risks include asthma-related events; not intended for acute exacerbations.
- Potential for paradoxical bronchospasm, which can worsen breathing.
- Monitor for glaucoma and urinary retention as serious side effects.
- Warning for hypokalemia (low potassium) and hyperglycemia (high blood sugar).
- Increased risk of death noted for patients with asthma using this medication.
Adverse Effects
- Common side effects include:
- Pharyngitis
- Sinusitis
- Lower respiratory tract infections
- Gastrointestinal disturbances such as constipation and diarrhea
- Pain in limbs and muscle spasms
- Neck and chest pain
Studying That Suits You
Use AI to generate personalized quizzes and flashcards to suit your learning preferences.
Description
Test your knowledge about Anoro Ellipta with these flashcards. Learn about its generic name, drug class, and usage in treating COPD. This quiz will help reinforce important details regarding this medication.
